Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
11/09/2024

Archive: 11/09/2024

More than half of UK government nutrition advisors are paid by food companies, research reveals

At least 11 of the 17 members of the Scientific Advisory Committee on Nutrition (SACN) have conflicts of interest with the likes of Nestle, sugar manufacturer Tate and Lyle, and the world's largest ice cream producer, Unilever, ...

Sep 11, 2024

0

27

Laughter may be as effective as drops for dry eye disease

Dry eye disease (DED) is a chronic condition estimated to affect around 360 million individuals worldwide. Common symptoms include uncomfortable, red, scratchy or irritated eyes.

Sep 11, 2024

0

5

Obesity treatments being restricted by cash poor local services across England, investigation finds

Patients in nearly half the country can't get appointments with specialist teams for weight-loss support and care, including treatment with drugs such as semaglutide. And in nearly one in five local health areas, patients ...

Sep 11, 2024

0

0

Study shows shorter-course radiation better option for breast cancer patients than conventional schedule

Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects and improves quality of life compared with a conventional schedule, finds ...

Sep 11, 2024

0

19

One dose of smallpox vaccine found to be moderately effective in preventing mpox infection

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a study published by The BMJ .

Sep 11, 2024

0

0

Tirzepatide associated with greater weight loss in women than men

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research ...

Sep 11, 2024

0

1

Rapid control of blood sugar levels in gestational diabetes can reverse risk of children developing obesity

Swiftly achieving glycemic control after a diagnosis of gestational diabetes can bring the baby's risk of obesity in childhood down to a level similar to that of children whose mothers did not have gestational diabetes, according ...

Sep 11, 2024

0

3

Semaglutide's cardiovascular benefits are maintained in people with impaired kidney function, research finds

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether ...

Sep 11, 2024

0

0

Large-scale population analysis confirms reassuring safety profile of tirzepatide

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged. Now real-world evidence from the FDA Adverse Event ...

Sep 11, 2024

0

37

Predictors for achieving, sustaining blood glucose control, weight loss with tirzepatide in adults with type 2 diabetes

The phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine (a long-acting insulin) for type 2 diabetes (T2D). Now new research examining ...

Sep 11, 2024

0

56

page 1 from 11

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us